Penumbra, Inc. ( PEN) - Key Metrics

PEN Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q2 $9.92 $0.89 $1.17 $0.83
2026Q1 $9.54 $0.83 $2.21 $1.87
2025Q4 $9.83 $1.21 $2.21 $1.74
2025Q3 $9.08 $1.17 $1.49 $1.08
2025Q2 $8.74 $1.17 $1.16 $0.76

PEN Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q2 0% 89.70
2026Q1 0% 98.91
2025Q4 0% 64.24
2025Q3 0% 54.13
2025Q2 0% 54.84

PEN Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q2 0.26% 0%
2026Q1 0.57% 0%
2025Q4 0.56% 0%
2025Q3 0.42% 0%
2025Q2 0.29% 0%

PEN

Price: $327.02

52 week price:
221.26
362.41

Earnings Per Share: 4.09 USD

P/E Ratio: 79.27

Exchange: NYQ

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 268800

Ebitda: 1.8 million

Market Capitalization: 12.8 billion

Links: